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ABSTRACT
Infantile systemic juvenile xanthogranuloma (ISJXG) is an uncommon form of juvenile xanthogranuloma, a non-Langerhans 
cell proliferation of infancy and early childhood. In a small percentage of patients, the visceral involvement—most 
commonly to the central nervous system, liver, spleen, or lungs—may be associated with severe morbidity, and eventually 
fatal outcome. Here we describe the clinical and pathological findings of a 28-day-old girl with ISJXG who died with 
respiratory distress syndrome. She had few cutaneous lesions but massive liver and spleen infiltration; other affected 
organs were multiple lymph nodes, thoracic parasympathetic nodule, pleura, pancreas, and kidneys. Additional findings 
were mild pulmonary hypoplasia and bacteremia. Immunohistochemistry on fixed tissues is the standard for diagnosis. 
Immunophenotype cells express CD14, CD68, CD163, Factor XIIIa, Stabilin-1, and fascin; S100 was positive in less than 
20% of the cases; CD1a and langerin were negative. No consistent cytogenetic or molecular genetic defect has been 
identified. This case demonstrates that the autopsy is a handy tool, because hepatic infiltration, which was not considered 
clinically, determined a restrictive respiratory impairment. In our opinion, this was the direct cause of death. 
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INTRODUCTION
Dendritic and histiocytic neoplasms are rare, 
and together make up less than 1% of neoplasms 
presenting in the lymph nodes or soft tissues.1 These 
tumors are usually classified into two main groups 
based on their derivation from either mesenchymal 
cells or bone marrow precursors.2,3 They occur less 
often during the perinatal period, and there is a study 
suggesting that there has been an increased incidence 
of spontaneous regression of certain histiocytic lesions 
in neonates compared to older individuals.4
Infantile systemic juvenile xanthogranuloma 
( ISJXG),  an uncommon non-Langerhans ce l l 
proliferation of infancy and early childhood,5,6 is 
one of the many clinical variants, with a common 
histopathology of the juvenile xanthogranuloma (JXG) 
family disorders namely (i) solitary or multiple dermal; 
(ii) infantile systemic; (iii) deep (soft tissue, “giant”); 
(iv) xanthoma disseminatum; (v) papular/generalized 
eruptive; (vi) benign cephalic histiocytosis; (vii) adult 
orbital XG; (viii) progressive nodular histiocytosis; and 
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(ix) Erdheim-Chester disease.5-8 Over the last decade, 
systemic forms have been increasingly reported.9
Stromal dendritic cells have been proposed 
(i.e., mesenchymal in origin) as the cells of origin, 
based on immunoreactivity to fascin and factor XIIIa. 
Immunohistochemistry, on fixed tissues, is the standard 
for diagnosis, and a panel of antibodies is required due 
to a lack of a unique cell marker.5-8
Although the biology of ISJXG is not clear, it often 
presents spontaneous regression over several years,4 
as in the isolated cutaneous form, the reason why the 
removal of these benign lesions is dissuaded. However, 
prompt and accurate diagnosis is essential. In a small 
percentage of patients with visceral involvement—
most commonly in the central nervous system (CNS), 
liver, spleen, or lungs—ISJXG may be associated with 
severe morbidity.10-14 Surgery, chemotherapy, and 
radiotherapy have been used with favorable results.10 
However, occasionally fatal outcome may occur.10,15
In a PubMed search, we found five reports of 
congenital fatal cases of ISJXG.8,13,15-23 Herein we 
describe the clinical and pathological findings of a 
28-day-old girl with congenital ISJXG who died with 
respiratory distress syndrome. In our opinion, the 
massive hepatomegaly caused lung restriction (which 
could have been present since the late gestation) 
hampering the pulmonary development, resulting in 
mild pulmonary hypoplasia. She had few cutaneous 
lesions but massive liver and spleen infiltration; other 
affected organs were multiple lymph nodes, the 
thoracic parasympathetic nodule, the pleura, the 
pancreas, and the kidneys. Additional findings were 
hypoplastic lungs and bacteremia.
CASE REPORT
This is the case of a 28-day-old girl without 
a remarkable family history, who was delivered at 
term after an uneventful pregnancy. She was born 
with counted bluish palpable nodular lesions from 
0.5 to 1 cm, which were initially located on the 
face. At the age of 21 days, she was presented to 
a general hospital with irritability and progressive 
abdominal distention. On admission, she was pale 
and presented 13 visible and 6 palpable skin nodules 
located on her face, thorax, and extremities, and 
massive hepatomegaly and splenomegaly. Blood 
tests showed mild anemia and thrombocytopenia. 
The abdominal echography revealed multiple nodular 
lesions throughout the enlarged liver. After 24 hours, 
the mother decided to take her to a tertiary care 
hospital, where clinically congenital leukemia was 
suspected. The anemia and thrombocytopenia 
worsened, but leukocytes were normal. Serologic 
studies for HIV, cytomegalovirus, Epstein-Barr virus and 
Toxoplasma were negative. Serum tumor markers as 
alpha-fetoprotein, human chorionic gonadotropin, and 
carcinoembryonic antigen were negative. The platelet 
count ranged from 4,000 to 18,000/ mm3 (reference 
range [RR]; 142-424 x 103/mm3), hemoglobin range 
was 7.5-11.3 g/dL (RR;12.2-18.1 g/dL); peripheral 
blood leukocyte count range was 4,580-8,520/mm3 
(RR; 4.60-10.20 x 103/mm3). Electrolytes showed 
persistent hyponatremia (sodium range 124-133 mEq/L 
[RR; 132-144 mEq/L]). However, potassium and 
renal function tests were within the normal limits. 
Three days after admission she was suffering from 
anasarca, and liver function tests showed low 
serum albumin 1.4 g/dL (RR; 3.50-5.00 g/dL) and 
notable coagulopathy with an increased Prothrombin 
Time and a I.N.R of 2.52 (RR; 1); serum aspartate 
aminotransferase range was 11-325 UI/L (RR; 12-50 UI/L), 
alanine aminotransferase range was 1.1-55 UI/L 
(RR; 10-40 UI/L), γ-glutamyl transpeptidase 24.3 UI/L 
(RR; 10-40 UI/L), total bilirubin range 2.59-8.75 mg/dL 
(RR; 0.20-1.00 mg/dL), alkaline phosphatase 38.54 UI/L 
(RR; 50-136 UI/L), and C-reactive protein 47.72 mg/L 
(RR;< 5 mg/L). Serum immunoglobulin levels were: 
IgG 169 mg/dL (RR; 100-360 mg/dL), IgM 14 mg/dL 
(RR; 26-122 mg/dL), IgA 3 mg/dL (RR; 7-37 mg/dL), 
and IgE 0.71 (UI/mL, <1.5). Serologic testing for syphilis 
was negative. A second abdominal ultrasound revealed 
retroperitoneal lymphadenopathy and ascites, and the 
kidneys were normal.
The clinical course following admission was of 
rapid deterioration with worsening hepatomegaly, 
hyperbilirubinemia, abdominal distention, abdominal 
circumference 43.5 cm (Figure 1A) and ascites, 
radiological thoracoabdominal images showed 
bilateral diaphragm elevation (Figure 1B) and intestinal 
distention.
On the fourth day a limited bone marrow aspirate 
showed no abnormal infiltrate or hemophagocytosis, 
and an excisional skin biopsy was taken. The patient 
died on the fifth day with respiratory distress syndrome 
(respiratory rate 70 breaths per minute), without 
evidence of hemorrhage.
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PATHOLOGIC FINDINGS
Due to the working diagnosis of congenital 
leukemia, a skin excisional biopsy was received and 
was evaluated immediately by fine needle aspiration 
(FNA) (caliber 26), which disclosed large histiocytic-like 
cells (Figure 2); therefore, the diagnosis of histiocytosis 
was suggested. The surgical specimen was studied on 
formalin-fixed and paraffin-embedded tissue sections.
Light microscopic study at low magnification 
revealed a dense cellular nodule poorly demarcated 
involving the entire dermis. At higher magnification, 
Figure 1. A – Gross examination of the corpse showing marked abdominal distention (abdominal circumference 
43.5 cm). Note the skin nodules (arrows) on the upper left extremity and lower right extremity, and genital edema; 
B – Plain thoraco-abdominal radiograph demonstrating the enlarged liver and diaphragm elevation.
Figure 2. Cytological example obtained by FNA of the skin biopsy. Disclosed monotonous histiocytic type cells. 
Cytologic features allowed us to suggest the diagnosis of histiocytosis. FNA = fine needle aspiration. (H&E stain), 
A (100 X), B (400 X).
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the predominant cells appeared to be histiocytes, with 
occasional eosinophils. There were few Touton giant 
cells (Figure 3), but no cells with foamy cytoplasm, 
nuclear atypia, or mitotic figures.
T h e  d i a g n o s i s  o f  J X G  w a s  m a d e . 
Immunohistochemical staining showed that all 
histiocytes were positive for CD68, CD163, and Factor 
XIIIa, and negative for S-100, CD1a, and langerin 
(Figure 4) (CD68/KP-1:700/Biocare, CD163/1:50/BioSb, 
Factor XIIIa/1:200/Biocare, S-100/1:3800/Dako, 
CD1a/1:500/Dako,  and langer in/1:40/BioSb, 
respectively).
Autopsy permission was restricted to the 
thoracic and abdominal organs. The infant had 
generalized edema, an abdominal circumference of 
43.5 cm, ascites, and mild jaundice. The postmortem 
examination revealed intense small bowel distention; 
the liver weighed 500 g (RR; 121 ±39.2 g); and was 
extensively infiltrated by irregular micronodular tumor 
(Figure 5).
At the cut surface, the liver gave off a fetid odor. 
The histology showed that tumor cells consisted of 
no plump histiocytes and spindle cell forms, and 
a few Touton giant cells were present. The tumor 
obliterated many portal and hepatic veins. In the 
liver, the tumor was preferentially located within the 
portal triads, but the biliary epithelium was spared 
(Figure 6).
Macroscopically the spleen was apparently free of 
tumor, but microscopically there were abundant plump 
histiocytic cells, positive for CD163, which obliterated 
the sinusoids (Figure 7).
Nodular tumor lesions were also present in the 
thoracic lymph nodes, pleura (Figure 8), mesenteric 
lymph nodes, perirectal fat (Figure 9), pancreas 
(Figure 10), periadrenal, and both kidneys (Figure 11). 
Multiple bacterial colonies were identified in the hepatic, 
splenic, and pulmonary vascular spaces (Figure 12), 
however, blood cultures were not performed. Other 
relevant findings were pulmonary atelectasis and 
mild pulmonary hypoplasia (Figure 13). Death was 
attributed to sepsis and respiratory distress syndrome 
secondary to pulmonary hypoplasia worsened by 
severe abdominal distention.
Figure 3. Photomicrographs of the skin biopsy showing dermal expansion for infiltration of histiocytes and occasional 
Touton giant and eosinophil cells (H&E stain) A (40X), B (100X), C (400 X), and D (400_X).
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Figure 4. Photomicrographs of the skin biopsy. Immunohistochemistry was positive for CD68 (A) and Factor XIIIa (C), 
and negative for CD1a (B) and S-100 (D).
Figure 5. Gross view of the liver showing the parenchyma diffusely infiltrated by the tumor.
DISCUSSION
The aid of recent advances in immunohistochemistry 
enabled better classification of dendritic and histiocytic 
cell neoplasms and improved the knowledge of tumor 
biology and histogenesis, which may be helpful in 
the management of these rare diseases. Dermal and 
interstitial dendrocytes are responsible for JXG.2,3 
JXG and Langerhans cell histiocytosis (LCH), together 
in the category of “dendritic cell-related proliferations”, 
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Figure 6. Photomicrographs of the liver. A, and C show the portal tract with diffuse infiltration by histiocytes and in B a 
central vein. The bile ducts are not affected, which is clearly seen with CD163. A (H&E, 100X), B (400X) and C (100X).
Figure 7. Photomicrographs of the spleen. A and B – High magnification of multisystemic juvenile xanthogranuloma 
with diffuse infiltration by plump histiocytes, which is strongly positive for CD163. A (H&E, 400X) and B (100X).
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Figure 8. Gross back view of the cardiopulmonary block showing yellowish pleural nodes in both lungs.
Figure 9. A – Gross view of the mesenteric and perirectal lymph nodes (C). The lymph nodes are infiltrated by foamy 
macrophages and Touton giant cells (B and D respectively) (H&E, B(40X) and D(400X).
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Figure 10. A – Gross view of the pancreas revealed nodular infiltration of the tale. The head of the organ shows a 
necrotic area surrounded by a hemorrhagic halo; B – Photomicrograph of the pancreas showing substitution of the 
normal parenchyma by the neoplasm. H&E (40X).
Figure 11. Gross view of the kidney in A and adrenal gland in B. The macroscopic examination shows nodular renal 
infiltration (asterisks) and periadrenal nodular lesion; C – Photomicrograph of the kidney with neoplastic infiltration 
(H&E, 100X) and D depicts the peripheral adrenal neoplastic nodule (H&E, 40X).
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Figure 12. Photomicrograph of the blood vessels with colonies of bacteria in the A – lung (H&E, 1000X); B – liver 
(H&E, 1000X); and C – spleen (H&E, 1000X).
Figure 13. Photomicrographs of the lung showing in A – nodular pleural infiltration (H&E, 100X); B – atelectasis 
(H&E, 40X), and at the periphery of an acinus in this hypoplastic lung (right); C – A radial count (arrow) is below the 
normal of 4 to 6 for a term infant, confirming the diagnosis of hypoplasia (H&E, 100X).
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currently are separated from the macrophage-related 
proliferations. The reported cases with the coexistence of 
JXG and LCH suggest their common origin.24,25 Patients 
with JXG and neurofibromatosis types 1 and 2, as well 
as a triad with juvenile chronic myelogenous leukemia, 
has been reported.26 In contrast to other Xanthomatous 
diseases, JXG is a normolipemic disorder.18,27
The Kiel Pediatric Tumor Registry reported 
129 cases of JXG over 36 year (0.52% among 
24,600 children), showing the very low frequency of 
the disease.8 JXG affects mainly children younger than 
2 years of age.8,28 In the analysis of Janssen and Harms,8 
there were 71.3% of patients younger than 12 months; 
in contrast, Dehner15 reported a frequency of 45% 
within the first year. According to various authors, the 
male to female ratio goes from “1.1:1” to .7:1”.8,26,29 
However, when considering only newborns, the ratio 
of male to female is 1:2.4 (Table 1). Clinically there is 
a broad spectrum of differential diagnoses, including 
reactive processes, or benign or malignant tumors.
The literature is replete with single-case reports of 
cutaneous JXG—the most common form of non-LCH 
of childhood—but JXG may occur at any site of the 
body, and only 4-5% of children with JXG have the 
infantile systemic variant of the disease.8,10,15,16,19,20,30,31 
A PubMed search revealed very few congenital and 
lethal ISJXG cases similar to ours (Table 1), with none 
having more than five affected sites; however, in our 
case, there were eight affected sites. In ISJXG, the 
most important morphologic differential diagnosis is 
with LCH, the most common form of dendritic cell 
proliferations.1-3
In ISJXG, the skin is involved in only 50% of 
cases, and the liver is involved in most of these cases, 
with predominantly portal infiltrate spilling over into 
the adjacent lobule but sparing the biliary tree, which 
contrasts with LCH.7 As Fan and Sun30 reported, when 
JXG has liver involvement, it is a relatively benign 
disease in its worst form. The location and character of 
hepatic lesions are important clues to the differential 
diagnosis, as reported by Favara.32 Other involved sites 
include: soft tissue, upper aerodigestive tract, CNS, 
lymph node, bone marrow, kidneys, and lung; other 
more unusual sites affected are spleen, myocardium, 
retroperitoneum, pancreas, and adrenal glands.33,34
From the 174 JXG cases reviewed by Denher,15 
8 had systemic disease, 2 were diagnosed at birth 
with hepatosplenomegaly and died of acute hepatic 
failure, but 1 survived after systemic chemotherapy. 
From 1996 to 2011 there were at last 31 informed 
cases of the clinical variant ISJXG; in 17 cases the 
condition was present at birth, 6 of these cases were 
fatal (35.2%) (Table 1). The reported ISJXG fatal cases 
of the neonates had a similar clinical presentation to 
our patient. This supports the concept that ISJXG, 
complicated by the hepatic infiltration in the neonatal 
period, is a life-threatening disease caused by hepatic 
failure, or mainly because severe hepatosplenomegaly 
induced respiratory failure, as happened in our case. 
The severe hepatosplenomegaly in our case could have 
been present since late gestation and compressed the 
thoracic cavity resulting in mild pulmonary hypoplasia 
by upward compression the diaphragm—a finding not 
previously reported in ISJXG.
This patient with JXG, which was apparently 
limited to the skin, must have had a complete physical 
examination to detect the systemic form, with 
laboratory and imaging studies if other abnormalities 
were suspected. Diagnostic studies may include 
computed tomography or magnetic resonance imaging 
(MRI), ultrasonography of the abdomen, a radionuclide 
bone scan, and a detailed ophthalmologic examination. 
In the instance of neonatal ISJXG where a quick 
diagnosis is required, FNA cytology made from the 
surgical biopsies is a useful tool for the initial differential 
diagnostic procedure and management.21,35,36 In our 
case, with the working diagnosis of congenital 
leukemia, the cytology of the skin biopsy allowed 
the proposed diagnosis of histiocytosis within a few 
minutes. Clinical presentations include anemia and 
thrombocytopenia; however, there is little reliable 
information on their natural history or the treatment 
of choice. The vast majority of congenital ISJXG cases, 
even those with visceral involvement, experience 
disease regression without specific treatment;4 
however, severe morbidity has been reported in 
some cases, which need supportive interventions and 
chemotherapy.10,22,28
Treatment protocols recommended for patients 
with symptoms who have unresectable lesions are 
those used for LCH. The LCH-III protocol—the most 
common treatment strategy—was first suggested 
by Nakatani et al.23 Although most patients with the 
multisystemic disease are infants and particularly 
susceptible to the adverse effects of chemotherapy, 
a prudent approach should emphasize the supportive 
Rodríguez-Velasco A, Rodríguez-Zepeda MC, Ortiz-Hidalgo C
11-14Autops Case Rep (São Paulo). 2019;9(2):e2018081
care, reserving chemotherapy or radiation when this 
treatment is perceived as necessary.
Immunophenotypically, cells express CD14, 
CD68, CD163, Factor XIIIa, Stabilin-1, and fascin; 
S100 is a variable positive in less than 20% of the 
cases; nevertheless, none of these markers are specific 
for ISJXG,37 and CD1a and langerin are negative. 
In our case, CD163 and Factor XIIIa were positive, 
Table 1. Reported cases of infantile systemic juvenile xanthogranuloma, detected at birth, with liver affection 
(n=17), searched in PubMed. Six cases (35.2%) were fatal
Author/year No. cases
Age at 
diagnosis
Sex Sites Treatment Outcome
Janssen and 
Harms8
1 Birth F Skin, lung, heart, 
liver, spleen, kidney, 
small and large 
intestine, BM
VP16, DX, Ig DOD, 34 days
Freyer et al.10 2 Birth
Birth
F
F
Skin, soft tissue, 
lung, liver, 
retroperitoneum
Bone, liver, spleen, 
adrenal gland
Supportive
MPD
Well/2 m
Well/2 y
Haughton et al.12 1 Birth F Skin, liver Liver transplantation ADF/2 y
Chantorn et al.13 2 (twins) Birth
Birth
F
F
Skin, liver
Skin, liver
PDN
PDN
AWD/17 m
Papadakis et al.14 1 Birth M Skin, liver VBL, VP16, 6-MP AWD/7.5 m
Dehner15 3 Birth
Birth*
Birth
M
M
F
Liver, spleen and 
lung
Skin, soft tissue, 
liver, spleen
Liver, spleen, 
adrenal, intestine 
and lymph nodes
VA, corticosteroids
CSA, VBL, MPN
VA, corticosteroids
DOD/2 m
ADF/8 y
DOD/1 m
Hu et al.16 1 Birth F Skin, liver, spleen, 
pancreas, adrenal 
gland, mesenteric 
lymph nodes
VP16, DX Died on day 29 from 
multiorgan failure 
and sepsis
Azorín et al.17 1 Birth F Skin, BM, liver MPN, VBL, 
Cytarabine, MTX and 
RT of the liver
DOD/78th day of life
Fan and Sun30 1 Birth M Liver, spleen, BM, 
lymph node, lung
PD, VBL, 6-MP and 
MTX
AWD/20 m
Takeuchi et al.19 1 Birth M Skin, placental, 
around portal vein
LCH oriented 
chemotherapy
ADF/2 y
Santiago et al.20 1 Birth F Soft tissue, liver, BM VBL, cytarabine Died on day 65 with 
septic shock
Nakatani et al.23 1 Birth F CNS, hip, liver and 
spleen
Cytarabine, 
vincristine, PDN, MTX
ADF/2 y
This case 1 Birth F Skin, liver, spleen, 
pancreas, kidneys, 
lymph nodes, pleura, 
parasympathetic 
nodes
Managed 
symptomatically
Died on day 120 
with respiratory 
distress and septic 
shock
*Previously reported by Freyer et al. J Pediatr 1996;129:227–37; 6-MP = 6-mercaptopurine; ADF = alive disease-free; 
AWD = alive with disease; BM = bone marrow; CNS = central nervous system; CSA = cyclosporine; DOD = dead of 
disease; DX = dexamethasone; F = female; Ig = immunoglobulins; LCH = Langerhans cell histiocytosis; M = male; 
MPN = metilprednisolone; MTX = methrotexate; PDN = prednisone; RT = radiation therapy; VA = Vinca alkaloids; 
VBL = vinblastine; VP16 = etopsoside.
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while S100 and CD1a were negative. No consistent 
cytogenetic or molecular genetic alterations have been 
identified.16,17
CONCLUSIONS
Infantile systemic forms of JXG have different 
presentation, response to the treatment and outcome. 
Incidence rates are about 0.1 case/1,000.000 of 
children younger than 15 years old. Although this 
report has the inherent limitation of a case report, it 
presents the importance of the autopsy examination, 
which can still influence medical practice and show 
several problems that were clinically undetected. 
In this case, the disseminated neoplasms could have 
been diagnosed earlier, because, in neonatal patients 
in whom JXG is considered, systemic forms could be 
underestimated, as in this case. For new patients with 
cutaneous JXG who have other symptoms, clinicians 
must be alert to refer the patient to a tertiary care 
center where tests, including (at the very least) MRI of 
the brain and ultrasonography of the abdomen, can 
be undertaken to enable accurate diagnosis. Adjuvant 
chemotherapy could have changed the course of the 
disease in our case. Although JXG is the most common 
benign type of histiocytosis in infants, the ISJXG variant 
is a very rare and distinctive clinicopathologic entity, 
generating a challenging group of patients. More than 
70% of the patients are younger than 1 year. ISJXG 
must be distinguished principally from LCH. The clinical 
findings are attributable to sites of disease and can be 
severe. No published case has eight affected sites of the 
body, as in our case. The most common sites of disease 
beyond subcutaneous soft tissue are liver, spleen 
(or both), lung, and CNS. Exceptionally, liver, spleen, 
or lung involvement cause serious consequences, 
and the gold standard for diagnosis is the biopsy. 
The respiratory distress and bacteremia, as in our case, 
may be the cause of death in most cases.
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